Advisory Committee on Immunization Practices (ACIP); Notice of Charter Amendment, 64896 [2019-25468]
Download as PDF
<![CDATA[
64896
Federal Register / Vol. 84, No. 227 / Monday, November 25, 2019 / Notices
information to, persons who seek access
to OGE Form 278 Public Financial
Disclosure Reports, including OGE
Form 278–T Periodic Transaction
Reports, and other covered records. The
form reflects the requirements of the
Ethics in Government Act, subsequent
amendments pursuant to the STOCK
Act, and OGE’s implementing
regulations that must be met by a person
before access can be granted. These
requirements include the address of the
requester, as well as any other person on
whose behalf a record is sought, and
acknowledgement that the requester is
aware of the prohibited uses of
executive branch public disclosure
financial reports. See 5 U.S.C. appendix
105(b) and (c) and 402(b)(1) and 5 CFR
2634.603(c) and (f). Executive branch
departments and agencies are
encouraged to utilize the OGE Form 201
for individuals seeking access to public
financial disclosure reports and other
covered documents. OGE permits
departments and agencies to use or
develop their own forms as long as the
forms collect and provide all of the
required information.
OGE recently revised its OGE/GOVT–
1, Executive Branch Personnel Public
Financial Disclosure Reports and Other
Name-Retrieved Ethics Program Records
system of records. The revisions were
published in the Federal Register on
September 9, 2019, and went into effect
on November 8, 2019. The revisions
included several new and modified
routine uses. The information collected
on the OGE Form 201 is maintained in
the OGE/GOVT–1 Governmentwide
system of records, and the form contains
a Privacy Act statement referencing
OGE/GOVT–1 as required by section
(e)(3) of the Privacy Act. Accordingly,
OGE proposes to update the Privacy Act
statement in accordance with changes to
the OGE/GOVT–1 system of records. No
other changes to the form are proposed.
This change will have no material effect
on the burden to filers.
Request for Comments: OGE is
publishing this first round notice of its
intent to request paperwork clearance
for a proposed modified OGE Form 201.
Agency and public comment is invited
specifically on the need for and
practical utility of this information
collection, the accuracy of OGE’s
burden estimate, the enhancement of
quality, utility and clarity of the
information collected, and the
minimization of burden (including the
use of information technology).
Comments received in response to this
notice will be summarized for and
included with the OGE request for
extension of OMB paperwork approval.
VerDate Sep<11>2014
17:31 Nov 22, 2019
Jkt 250001
The comments will also become a
matter of public record.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Approved: November 20, 2019.
Emory Rounds,
Director, U.S. Office of Government Ethics.
Centers for Disease Control and
Prevention
[FR Doc. 2019–25515 Filed 11–22–19; 8:45 am]
BILLING CODE 6345–03–P
Board of Scientific Counselors,
National Center for Health Statistics
(BSC, NCHS)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP); Notice of Charter
Amendment
This gives notice under the Federal
Advisory Committee Act of October 6,
1972, that the Advisory Committee on
Immunization Practices (ACIP), Centers
for Disease Control and Prevention,
Department of Health and Human
Services, has amended their charter to
include a non-voting liaison
representative; American Immunization
Registry Association. The amended
filing date is October 22, 2019.
FOR FURTHER INFORMATION CONTACT:
Amanda Cohn, M.D., Designated
Federal Officer, Advisory Committee on
Immunization Practices, Centers for
Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE,
Mailstop A27, Atlanta, Georgia 30329–
4027, telephone (404) 639–6039, or fax
(404) 315–4679.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–25468 Filed 11–22–19; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Health Statistics
BSC, NCHS. This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. For foreign nationals or
non-U.S. citizens, pre-approval is
required (please contact Gwen Mustaf,
301–458–4500, glm4@cdc.gov or
Sayeedha Uddin, 301–458–4303, isx9@
cdc.gov at least 4 weeks in advance for
requirements). All visitors are required
to present a valid form of picture
identification issued by a state, federal
in international government. As
required by the Federal Property
Management Regulations, Title 41, Code
of Federal Regulations, Subpart 101–
20.301, all persons entering in or on
Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. The meeting room
accommodates approximately 78
people.
SUMMARY:
The meeting will be held on
January 9, 2020, 11:00 a.m.–5:30 p.m.,
EDT, and January 10, 2020, 8:30 a.m.–
1:00 p.m., EDT.
ADDRESSES: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
DATES:
FOR FURTHER INFORMATION CONTACT:
Sayeedha Uddin, M.D., M.P.H.,
Executive Secretary, NCHS/CDC, Board
of Scientific Counselors, 3311 Toledo
Road, Room 2627, Hyattsville, Maryland
20782; telephone (301) 458–4303; email
isx9@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 84, Number 227 (Monday, November 25, 2019)]
[Notices]
[Page 64896]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25468]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP); Notice of
Charter Amendment
This gives notice under the Federal Advisory Committee Act of
October 6, 1972, that the Advisory Committee on Immunization Practices
(ACIP), Centers for Disease Control and Prevention, Department of
Health and Human Services, has amended their charter to include a non-
voting liaison representative; American Immunization Registry
Association. The amended filing date is October 22, 2019.
FOR FURTHER INFORMATION CONTACT: Amanda Cohn, M.D., Designated Federal
Officer, Advisory Committee on Immunization Practices, Centers for
Disease Control and Prevention, Department of Health and Human
Services, 1600 Clifton Road NE, Mailstop A27, Atlanta, Georgia 30329-
4027, telephone (404) 639-6039, or fax (404) 315-4679.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-25468 Filed 11-22-19; 8:45 am]
BILLING CODE 4163-18-P
